Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach
- PMID: 18098321
- DOI: 10.1002/hep.22009
Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach
Abstract
Nonalcoholic fatty liver disease (NAFLD) is systematically associated with insulin resistance and the metabolic syndrome, where behavior therapy remains the primary treatment, simultaneously addressing all the clinical and biochemical defects. However, very few studies have tested the effectiveness of intensive behavior therapy in NAFLD, aimed at lifestyle modifications to produce stable weight loss by reduced calorie intake and increased physical activity. Searching the literature for studies testing weight loss and lifestyle modifications for the treatment of NAFLD, only 14 reports were traced where the entry assessment satisfied well-defined criteria. The final effectiveness was based on hard histological outcomes in 5 cases. All but 1 were pilot, uncontrolled studies or limited case series, and in general the details of treatment were scanty. In only 3 cases treatment was carried out along the guidelines of behavior treatment to reduce excess nutrition and increase exercise; in these cases, a remarkable effect on weight loss and an improvement in liver histology were reported. The principles of behavior therapy are presented in detail, to help physicians change their prescriptive attitude into a more empowerment-based approach. A brief section is also included on the practical aspects and public policies to be implemented at societal level to obtain the maximum effects in lifestyle changes. There is a need for multidisciplinary teams including dietitians, psychologists, and physical activity supervisors caring for patients with NAFLD. Alternatively, general practitioners and physicians working in gastrointestinal units should limit their intervention to engage patients with NAFLD before referral to specialized teams set up for the treatment of diabetes and obesity.
Similar articles
-
Weight loss as a treatment for nonalcoholic fatty liver disease.J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S39-43. doi: 10.1097/01.mcg.0000168641.31321.fa. J Clin Gastroenterol. 2006. PMID: 16540766 Review.
-
The effect of lifestyle changes in non-alcoholic fatty liver disease.Dig Dis. 2010;28(1):267-73. doi: 10.1159/000282101. Epub 2010 May 7. Dig Dis. 2010. PMID: 20460922 Review.
-
Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.J Gastroenterol Hepatol. 2009 Mar;24(3):399-407. doi: 10.1111/j.1440-1746.2008.05694.x. Epub 2008 Dec 2. J Gastroenterol Hepatol. 2009. PMID: 19067776 Clinical Trial.
-
Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease.Expert Rev Gastroenterol Hepatol. 2008 Apr;2(2):217-31. doi: 10.1586/17474124.2.2.217. Expert Rev Gastroenterol Hepatol. 2008. PMID: 19072357 Review.
-
Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.Clin Ther. 2008 Jun;30(6):1168-76. doi: 10.1016/j.clinthera.2008.06.012. Clin Ther. 2008. PMID: 18640473 Clinical Trial.
Cited by
-
Changes in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob mice.PLoS One. 2010 Nov 5;5(11):e13858. doi: 10.1371/journal.pone.0013858. PLoS One. 2010. PMID: 21079772 Free PMC article.
-
Effects of Exercise Intervention in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease.J Obes Metab Syndr. 2025 Jul 30;34(3):239-252. doi: 10.7570/jomes25028. Epub 2025 Jul 11. J Obes Metab Syndr. 2025. PMID: 40641101 Free PMC article. Review.
-
Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial.Therap Adv Gastroenterol. 2013 Jul;6(4):249-59. doi: 10.1177/1756283X13484078. Therap Adv Gastroenterol. 2013. PMID: 23814606 Free PMC article.
-
Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status.Adv Ther. 2009 Oct;26(10):893-907. doi: 10.1007/s12325-009-0072-z. Epub 2009 Nov 16. Adv Ther. 2009. PMID: 19921118 Free PMC article. Review.
-
Nonalcoholic fatty liver disease.J Lipid Res. 2009 Apr;50 Suppl(Suppl):S412-6. doi: 10.1194/jlr.R800089-JLR200. Epub 2008 Dec 12. J Lipid Res. 2009. PMID: 19074370 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources